Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces DHT levels and affects gene expression in fish, similar to its effects in humans.

Baicalin may effectively treat hair loss by inhibiting 5α-reductase.

A rare gene variant causes sexual development issues in siblings, needing personalized treatment.

DNA analysis can help tailor alopecia treatment.

Adding Triamcinolone to the anesthetic can reduce swelling after hair transplants, and using Platelet-Rich Plasma can improve hair thickness and patient satisfaction. The SRD5A2 gene also plays a key role in the success of hair transplants.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Shorter GGC triplet repeats in the androgen receptor gene are linked to less hair loss in Han men.

The research helps understand how finasteride works and aids drug development.

Older parental age, rural living, and specific genetic mutations increase hypospadias risk in children.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

5α-Reductase inhibitors can negatively impact sexual function.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.